Related Experiment Video

Updated: May 10, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn

Tzu-Hsuan Huang1, Longfei Huo, Ying-Nai Wang

  • 1Department of Molecular and Cellular Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.

Cancer Cell
|June 15, 2013
PubMed

Insights

Epidermal growth factor receptor (EGFR) activates Lyn kinase, which then phosphorylates MCM7. This promotes DNA replication and cell proliferation, impacting breast cancer patient survival.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Cancer research

Background:

  • Epidermal growth factor receptor (EGFR) signaling drives cell proliferation.
  • The precise role of EGFR in DNA replication licensing remains incompletely understood.
  • DNA replication licensing is crucial for cell cycle progression.

Purpose of the Study:

  • To elucidate the role of EGFR in regulating DNA replication licensing.
  • To identify key molecular players in the EGFR-mediated DNA synthesis pathway.
  • To investigate the clinical relevance of identified signaling events in breast cancer.

Main Methods:

  • Western blotting to detect protein phosphorylation.
  • Immunoprecipitation to assess protein-protein interactions.
  • Analysis of patient survival data.

Main Results:

  • Activated EGFR phosphorylates p56 Lyn at Y32.
  • Phosphorylated p56 Lyn (p56(Lyn) Y32) phosphorylates MCM7 at Y600.
  • Increased phosphorylation of p56 Lyn and MCM7 correlates with proliferation and poorer survival in breast cancer patients.

Conclusions:

  • EGFR signaling enhances DNA replication licensing through Lyn and MCM7 phosphorylation.
  • This pathway promotes cell proliferation in human cancer cells.
  • The EGFR-Lyn-MCM7 axis represents a potential therapeutic target in breast cancer.

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...